[LGND] QoQ Quarter Result on 30-Sep-2018 [#Q3]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
08-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- -7.93%
YoY- 699.45%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue 24,987 43,484 59,590 45,663 90,043 56,157 50,464 -37.49%
PBT -18,028 842,713 -56,789 79,226 95,579 55,312 30,665 -
Tax -3,609 176,376 -14,307 11,864 22,419 10,033 37,675 -
NP -14,419 666,337 -42,482 67,362 73,160 45,279 -7,010 61.95%
Tax Rate - -20.93% - -14.97% -23.46% -18.14% -122.86% -
Total Cost 39,406 -622,853 102,072 -21,699 16,883 10,878 57,474 -22.29%
Ratio Analysis
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin -57.71 1,532.37 -71.29 147.52 81.25 80.63 -13.89 159.11%
Per Share
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
EPS -0.74 32.59 -2.02 3.19 3.45 2.13 -0.34 68.18%
EPS Diluted -0.74 31.32 -2.02 2.80 2.99 1.83 -0.33 71.57%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.